p38 MAPK Inhibitor NJK14047 Suppresses CDNB-Induced Atopic Dermatitis-Like Symptoms in BALB/c Mice |
Lee, Ju-Hyun
(Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University)
Son, Seung-Hwan (Department of Basic Pharmaceutical Sciences, Graduate School, Kyung Hee University) Kim, Nam-Jung (Department of Basic Pharmaceutical Sciences, Graduate School, Kyung Hee University) Im, Dong-Soon (Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University) |
1 | Muraro, A., Lemanske, R. F., Jr., Hellings, P. W., Akdis, C. A., Bieber, T., Casale, T. B., Jutel, M., Ong, P. Y., Poulsen, L. K., Schmid-Grendelmeier, P., Simon, H. U., Seys, S. F. and Agache, I. (2016) Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J. Allergy Clin. Immunol. 137, 1347-1358. DOI |
2 | Liu, F.-T., Goodarzi, H. and Chen, H.-Y. (2011) IgE, mast cells, and eosinophils in atopic dermatitis. Clin. Rev. Allergy Immunol. 41, 298-310. DOI |
3 | Min, G.-Y., Kim, J.-H., Kim, T.-I., Cho, W.-K., Yang, J.-H. and Ma, J.-Y. (2022) Indigo Pulverata Levis (Chung-Dae, Persicaria tinctoria) alleviates atopic dermatitis-like inflammatory responses in vivo and in vitro. Int. J. Mol. Sci. 23, 553. DOI |
4 | Nath, P., Leung, S.-Y., Williams, A., Noble, A., Chakravarty, S. D. S., Luedtke, G. R., Medicherla, S., Higgins, L. S., Protter, A. and Chung, K. F. (2006) Importance of p38 mitogen-activated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness. Eur. J. Pharmacol. 544, 160-167. DOI |
5 | Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suarez-Farinas, M., Cardinale, I., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., Pensabene, C., Coats, I., Novitskaya, I., Lowes, M. A. and Krueger, J. G. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159, 1092-1102. |
6 | Ono, K. and Han, J. (2000) The p38 signal transduction pathway activation and function. Cell. Signal. 12, 1-13. DOI |
7 | Schafer, P. H., Wadsworth, S. A., Wang, L. and Siekierka, J. J. (1999) p38α mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+ CD45RO+ T cells and Th2 effector cells. J. Immunol. 162, 7110-7119. DOI |
8 | Souwer, Y., Szegedi, K., Kapsenberg, M. L. and de Jong, E. C. (2010) IL-17 and IL-22 in atopic allergic disease. Curr. Opin. Immunol. 22, 821-826 DOI |
9 | Niiro, H. and Clark, E. A. (2002) Regulation of B-cell fate by antigenreceptor signals. Nat. Rev. Immunol. 2, 945-956. DOI |
10 | Nel, A. E. (2002) T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J. Allergy Clin. Immunol. 109, 758-770. DOI |
11 | Nograles, K. E., Zaba, L. C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., Ramon, M., Bergman, R., Krueger, J. G. and Guttman-Yassky, E. (2009) IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J. Allergy Clin. Immunol. 123, 1244-1252. e2. DOI |
12 | Oh, M.-H., Oh, S. Y., Yu, J., Myers, A. C., Leonard, W. J., Liu, Y. J., Zhu, Z. and Zheng, T. (2011) IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin. J. Immunol. 186, 7232-7242. DOI |
13 | Park, S. J. and Im, D. S. (2019) Blockage of sphingosine-1-phosphate receptor 2 attenuates allergic asthma in mice. Br. J. Pharmacol. 176, 938-949. DOI |
14 | Buyanravjikh, S., Han, S., Lee, S., Jeong, A. L., Ka, H. I., Park, J. Y., Boldbaatar, A., Lim, J. S., Lee, M. S. and Yang, Y. (2018) Cryptotanshinone inhibits IgE-mediated degranulation through inhibition of spleen tyrosine kinase and tyrosine-protein kinase phosphorylation in mast cells. Mol. Med. Rep. 18, 1095-1103. |
15 | Vestergaard, C., Yoneyama, H., Murai, M., Nakamura, K., Tamaki, K., Terashima, Y., Imai, T., Yoshie, O., Irimura, T., Mizutani, H. and Matsushima, K. (1999) Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104, 1097-1105. DOI |
16 | Akdis, C. A., Akdis, M., Bieber, T., Bindslev-Jensen, C., Boguniewicz, M., Eigenmann, P., Hamid, Q., Kapp, A., Leung, D. Y., Lipozencic, J., Luger, T. A., Muraro, A., Novak, N., Platts-Mills, T. A., Rosenwasser, L., Scheynius, A., Simons, F. E., Spergel, J., Turjanmaa, K., Wahn, U., Weidinger, S., Werfel, T. and Zuberbier, T.; European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology (2006) Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report. J. Allergy Clin. Immunol. 118, 152-169. |
17 | Bai, X.-Y., Liu, P., Chai, Y.-W., Wang, Y., Ren, S.-H., Li, Y.-Y. and Zhou, H. (2020) Artesunate attenuates 2, 4-dinitrochlorobenzeneinduced atopic dermatitis by down-regulating Th17 cell responses in BALB/c mice. Eur. J.Pharmacol. 874, 173020. DOI |
18 | Bantz, S. K., Zhu, Z. and Zheng, T. (2014) The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J. Clin. Cell. Immunol. 5, 202. |
19 | Blume-Peytavi, U. and Wahn, U. (2011) Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate. J. Eur. Acad. Dermatol. Venereol. 25, 508-515. DOI |
20 | Chen, C.-H., Zhang, D.-H., LaPorte, J. M. and Ray, A. (2000) Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J. Immunol. 165, 5597-5605. DOI |
21 | Chen, L., Martinez, O., Overbergh, L., Mathieu, C., Prabhakar, B. and Chan, L. (2004) Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin. Exp. Immunol. 138, 375-387. DOI |
22 | Duan, W., Chan, J. H., McKay, K., Crosby, J. R., Choo, H. H., Leung, B. P., Karras, J. G. and Wong, W. F. (2005) Inhaled p38α mitogenactivated protein kinase antisense oligonucleotide attenuates asthma in mice. Am. J. Respir. Crit. Care Med. 171, 571-578. DOI |
23 | Chen, Y., Xian, Y. F., Loo, S., Lai, Z., Chan, W. Y., Liu, L. and Lin, Z. X. (2020) Huang-Lian-Jie-Du extract ameliorates atopic dermatitislike skin lesions induced by 2,4-dinitrobenzene in mice via suppression of MAPKs and NF-κB pathways. J. Ethnopharmacol. 249, 112367. DOI |
24 | Choi, M.-S., Heo, J., Yi, C.-M., Ban, J., Lee, N.-J., Lee, N.-R., Kim, S. W., Kim, N.-J. and Inn, K.-S. (2016) A novel p38 mitogen activated protein kinase (MAPK) specific inhibitor suppresses respiratory syncytial virus and influenza A virus replication by inhibiting virusinduced p38 MAPK activation. Biochem. Biophys. Res. Commun. 477, 311-316. DOI |
25 | Davidson, W. F., Leung, D. Y. M., Beck, L. A., Berin, C. M., Boguniewicz, M., Busse, W. W., Chatila, T. A., Geha, R. S., Gern, J. E., Guttman-Yassky, E., Irvine, A. D., Kim, B. S., Kong, H. H., Lack, G., Nadeau, K. C., Schwaninger, J., Simpson, A., Simpson, E. L., Spergel, J. M., Togias, A., Wahn, U., Wood, R. A., Woodfolk, J. A., Ziegler, S. F. and Plaut, M. (2019) Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: mechanisms and interventions". J. Allergy Clin. Immunol. 143, 894-913. |
26 | Hengge, U. R., Ruzicka, T., Schwartz, R. A. and Cork, M. J. (2006) Adverse effects of topical glucocorticosteroids. J. Am. Acad. Dermatol. 54, 1-15. DOI |
27 | Koprak, S., Staruch, M. J. and Dumont, F. J. (1999) A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production. Cell. Immunol. 192, 87-95. DOI |
28 | Kumar, S., Boehm, J. and Lee, J. C. (2003) p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2, 717-726. DOI |
29 | Gee, M. S., Kim, S.-W., Kim, N., Lee, S. J., Oh, M. S., Jin, H. K., Bae, J.-S., Inn, K.-S., Kim, N.-J. and Lee, J. K. (2018) A novel and selective p38 mitogen-activated protein kinase inhibitor attenuates LPS-induced neuroinflammation in BV2 microglia and a mouse model. Neurochem. Res. 43, 2362-2371. DOI |
30 | Hale, K. K., Trollinger, D., Rihanek, M. and Manthey, C. L. (1999) Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ, and δ in inflammatory cell lineages. J. Immunol. 162, 4246-4252. DOI |
31 | Huang, J., Su, M., Lee, B. K., Kim, M. J., Jung, J. H. and Im, D. S. (2018) Suppressive effect of 4-hydroxy-2-(4-hydroxyphenethyl) isoindoline-1,3-dione on ovalbumin-induced allergic asthma. Biomol. Ther. (Seoul) 26, 539-545. DOI |
32 | Imai, Y. (2019) Interleukin-33 in atopic dermatitis. J. Dermatol. Sci. 96, 2-7. DOI |
33 | Kang, J. and Im, D. S. (2020) FFA2 activation ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice. Biomol. Ther. (Seoul) 28, 267-271. DOI |
34 | Kawakami, T. and Galli, S. J. (2002) Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2, 773-786. Kim, J. Y., Jeong, M. S., Park, M. K., Lee, M. K. and Seo, S. J. (2014) Time-dependent progression from the acute to chronic phases in atopic dermatitis induced by epicutaneous allergen stimulation in NC/Nga mice. Exp. Dermatol. 23, 53-57. |
35 | Maneechotesuwan, K., Xin, Y., Ito, K., Jazrawi, E., Lee, K.-Y., Usmani, O. S., Barnes, P. J. and Adcock, I. M. (2007) Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA3. J. Immunol. 178, 2491-2498. DOI |
36 | Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Heys, J. R., Landvatter, S. W., Strickler, J. E., McLaughlin, M. M., Siemens, I. R., Fisher, S. M., Livi, G. P., White, J. R., Adams, J. L. and Young, P. R. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746. DOI |
37 | Leung, D. Y. and Guttman-Yassky, E. (2017) Assessing the current treatment of atopic dermatitis: unmet needs. J. Allergy Clin. Immunol. 139, S47-S48. DOI |
38 | Leung, D. Y. and Soter, N. A. (2001) Cellular and immunologic mechanisms in atopic dermatitis. J. Am. Acad. Dermatol. 44, S1-S12. DOI |
39 | Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M. and Tokura, Y. (2008) Possible pathogenic role of Th17 cells for atopic dermatitis. J. Invest. Dermatol. 128, 2625-2630. DOI |
40 | Lu, B., Ferrandino, A. F. and Flavell, R. A. (2004) Gadd45β is important for perpetuating cognate and inflammatory signals in T cells. Nat. Immunol. 5, 38-44. DOI |
41 | Mori, A., Kaminuma, O., Miyazawa, K., Ogawa, K., Okudaira, H. and Akiyama, K. (1999) p38 mitogen-activated protein kinase regulates human T cell IL-5 synthesis. J. Immunol. 163, 4763-4771. DOI |
42 | Underwood, D. C., Osborn, R. R., Kotzer, C. J., Adams, J. L., Lee, J. C., Webb, E. F., Carpenter, D. C., Bochnowicz, S., Thomas, H. C., Hay, D. W. and Griswold, D. E. (2000) SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J. Pharmacol. Exp. Ther. 293, 281-288. |
43 | Escott, K., Belvisi, M., Birrell, M., Webber, S., Foster, M. and Sargent, C. (2000) Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat. Br. J. Pharmacol. 131, 173-176. DOI |
44 | Saklatvala, J. (2004) The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Cur. Opin. Pharmacol. 4, 372-377. DOI |
45 | Skapenko, A., Lipsky, P. E., Kraetsch, H.-G., Kalden, J. R. and Schulze-Koops, H. (2001) Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation. J. Immunol. 166, 4283-4292. DOI |
46 | Song, H.-Y., Kim, W. S., Mushtaq, S., Park, J. M., Choi, S.-H., Cho, J.-W., Lim, S.-T. and Byun, E.-B. (2019) A novel chrysin derivative produced by gamma irradiation attenuates 2, 4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in Balb/cmice. Food Chem. Toxicol. 128, 223-232. DOI |
47 | Spergel, J. M., Mizoguchi, E., Oettgen, H., Bhan, A. K. and Geha, R. S. (1999) Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J. Clin. Invest. 103, 1103-1111. DOI |
48 | Kalesnikoff, J., Huber, M., Lam, V., Damen, J. E., Zhang, J., Siraganian, R. P. and Krystal, G. (2001) Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 14, 801-811. DOI |
49 | Gee, M. S., Son, S. H., Jeon, S. H., Do, J., Kim, N., Ju, Y.-J., Lee, S. J., Chung, E. K., Inn, K.-S., Kim, N.-J. and Lee, J. K. (2020) A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse. Alzheimer's Res. Ther. 12, 45. DOI |
50 | Heo, J., Shin, H., Lee, J., Kim, T., Inn, K.-S. and Kim, N.-J. (2015) Synthesis and biological evaluation of N-cyclopropylbenzamidebenzophenone hybrids as novel and selective p38 mitogen activated protein kinase (MAPK) inhibitors. Bioorg. Med. Chem. Lett. 25, 3694-3698. DOI |
51 | Kim, S.-Y., Kim, H., Kim, S.-W., Lee, N.-R., Yi, C.-M., Heo, J., Kim, B.- J., Kim, N.-J. and Inn, K.-S. (2017) An effective antiviral approach targeting hepatitis B virus with NJK14047, a novel and selective biphenyl amide p38 mitogen-activated protein kinase inhibitor. Antimicrob. Agents Chemother. 61, e00214-17. |
52 | Ku, J. M., Hong, S. H., Kim, S. R., Choi, H.-S., Kim, H. I., Kim, D. U., Oh, S. M., Seo, H. S., Kim, T. Y., Shin, Y. C., Cheon, C. and Ko, S. G. (2018) The prevention of 2,4-dinitrochlorobenzene-induced inflammation in atopic dermatitis-like skin lesions in BALB/c mice by Jawoongo. BMC Complement. Altern. Med. 18, 215. DOI |
53 | Lee, J. M., Park, S. J. and Im, D. S. (2017) Calcium signaling of lysophosphatidylethanolamine through LPA1 in human SH-SY5Y neuroblastoma cells. Biomol. Ther. (Seoul) 25, 194-201. DOI |
54 | Zhang, R., Zhang, H., Shao, S., Shen, Y., Xiao, F., Sun, J., Piao, S., Zhao, D., Li, G. and Yan, M. (2022) Compound traditional Chinese medicine dermatitis ointment ameliorates inflammatory responses and dysregulation of itch-related molecules in atopic dermatitis. Chin. Med. 17, 3. DOI |